Indapamide Krka 1.5 mg prolonged-release tablets

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Indapamide Krka is and what it is used for
2. What you need to know before you take Indapamide Krka
3. How to take Indapamide Krka
4. Possible side effects
5. How to store Indapamide Krka
6. Contents of the pack and other information

• if you are allergic to indapamide or any of the other ingredients of this medicine or to other drugs of the same type (called sulphonamides) (listed in section 6).
• if you have severe impairment of kidney function.
• if you have severe impairment of liver or suffer from a condition called hepatic encephalopathy (degenerative disease of the brain).
• if you have low level of potassium in your blood.

Talk to your doctor or pharmacist before taking Indapamide Krka.

• if you have impairment of liver function.
• if you have diabetes.
• if you have gout.
• if you have impairment of kidney function.
• if you have any heart rhythm problems.
• if you need to have a test to check how well your parathyroid gland is working.

You should tell your doctor if you had photosensitivity reactions.

If you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to a week of taking Indapamide Krka. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this.

Your doctor may give you blood tests to check for low sodium or potassium levels or high calcium levels.

If you think any of these situations may apply to you or you have any questions or doubts about taking your medicine, you should consult your doctor or pharmacist.

Athletes should be aware that this medicine contains an active ingredient, which may give a positive reaction in doping tests.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

You should not take Indapamide Krka with lithium (used to treat depression) due to the risk of increased levels of lithium in the blood.

Make sure to tell your doctor if you are taking any of the following medicines, as special care may be required:

• medicines used for heart rhythm problems (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, ibutilide, dofetilide, digitalis),
• medicines used to treat mental disorders such as depression, anxiety, schizophrenia (e.g. tricyclic antidepressants, antipsychotic drugs, neuroleptics),
• bepridil (used to treat angina pectoris, a condition causing chest pain),
• cisapride, diphemanil (used to treat gastro-intestinal problems),
• sparfloxacin, moxifloxacin, erythromycin by injection (antibiotics used to treat infections),
• vincamine by injection (used to treat symptomatic cognitive disorders in elderly including memory loss),
• halofantrine (antiparasitic drug used to treat certain types of malaria),
• pentamidine (used to treat certain types of pneumonia),
• mizolastine (used to treat allergic reactions, such as hay fever),
• non-steroidal anti-inflammatory drugs for pain relief (e.g. ibuprofen) or high doses of acetylsalicylic acid,
• angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure and heart failure),
• amphotericin B by injection (anti-fungal medicines),
• oral corticosteroids used to treat various conditions including severe asthma and rheumatoid arthritis,
• stimulant laxatives,
• baclofen (to treat muscle stiffness occurring in diseases such as multiple sclerosis),
• potassium-sparing diuretics (amiloride, spironolactone, triamterene),
• allopurinol (for the treatment of gout),
• metformin (to treat diabetes),
• iodinated contrast media (used for tests involving X-rays),
• calcium tablets or other calcium supplements,
• ciclosporin, tacrolimus or other medicines to depress the immune system after organ transplantation, to treat autoimmune diseases, or severe rheumatic or dermatological diseases,
• tetracosactide (to treat Crohn’s disease).

Food and drink have no influence on the effect of Indapamide Krka.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

This medicine is not recommended during pregnancy. When a pregnancy is planned or confirmed, the switch to an alternative treatment should be initiated as soon as possible.

Please tell your doctor if you are pregnant or wish to become pregnant.

The active ingredient is excreted in milk. Breast-feeding is not advisable if you are taking this medicine.

This medicine can cause side effects due to low blood pressure such as dizziness or tiredness (see section 4). These side effects are more likely to occur at beginning of therapy or increasing the dose. If this occurs you should refrain from driving or other activities requiring alertness. However, under good control, these side effects are unlikely to occur.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

If you have taken a higher dose of the drug than you should, consult your doctor or pharmacist immediately.

A very large dose of Indapamide Krka could cause nausea, vomiting, low blood pressure, cramps, dizziness, drowsiness, confusion and changes in the amount of urine produced by the kidneys.

If you forget to take Indapamide Krka at the right time, follow your usual dosing schedule by taking your next dose at the scheduled time.

Do not take a double dose to make up for a forgotten tablet.

As the treatment for high blood pressure is usually life-long, you should discuss with your doctor before stopping this medicinal product.

• angioedema and/or urticaria. Angioedema is characterised by swelling of the skin extremities or face, swelling of the lips or tongue, swelling of the mucous membranes of the throat or airways resulting in shortness of the breath or difficulty of swallowing. It this occurs, contact your doctor immediately. (Very rare) (may affect up to 1 in 10,000 people)
• severe skin reactions including intense skin rash, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Steven Johnson syndrome) or other allergic reactions. (Very rare) (may affect up to 1 in 10,000 people)
• life-threatening irregular beat. (Not known)
• inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell. (Very rare) (may affect up to 1 in 10,000 people)
• disease of the brain caused by liver illness (hepatic encephalopathy). (Not known)
• inflammation of the liver (Hepatitis). (Not known)

The frequency of side effects listed below is defined according to the following categories:

Common (may affect up to 1 in 10 people):

• low potassium in the blood;
• red raised skin rash;
• allergic reactions, mainly dermatological, in subjects with a predisposition to allergic and asthmatic reactions.

Uncommon (may affect up to 1 in 100 people):

• low sodium in the blood that may lead to dehydration and low blood pressure;
• vomiting;
• red pinpoints on skin
• impotence (inability to obtain or maintain an erection).

Rare (may affect up to 1 in 1,000 people):

• feeling of tiredness, headache, pins and needles (paraesthesia), vertigo;
• gastro-intestinal disorders (such as nausea, constipation), dry mouth;
• low chloride in the blood, low magnesium in the blood.

Very rare (may affect up to 1 in 10,000 people):

• changes in blood cells, such as thrombocytopenia (decrease in the number of platelets which causes easy bruising and nasal bleeding), leucopenia (decrease of white blood cells which may cause unexplained fever, soreness of the throat or other flu-like symptoms – if this occurs, contact your doctor) and anaemia (decrease in red blood cells);
• high level of calcium in blood;
• heart rhythm irregularities (causing palpitations, feeling of the heart pounding), low blood pressure;
• kidney disease (causing symptoms of tiredness, increased need to urinate, itchy skin, feeling sick, swollen extremities);
• abnormal hepatic function.

Not known (frequency cannot be estimated from the available data):

• fainting;
• if you suffer from systemic lupus erythematosus (a disorder of the immune system leading to inflammation and damage to the joints, tendons and organs with symptoms including skin rashes, tiredness, loss of appetite, weight gain and joint pain), this might get worse;
• cases of photosensitivity reactions (change in skin appearance) after exposure to the sun or artificial UVA have also been reported;
• short sightedness (myopia);
• blurred vision;
• visual impairment;
• decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma);
• impotence;
• changes may occur in your blood and your doctor may need to give you blood tests to check your condition. The following changes in laboratory parameters may occur:
  • increase in uric acid, a substance which may cause or worsen gout (painful joint(s) especially in the feet),
  • increase in blood glucose levels in diabetic patients,
  • increased levels of liver enzymes;
• abnormal ECG heart tracing.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

• The active substance is indapamide. Each prolonged-release tablet contains 1.5 mg indapamide.
• The other ingredients (excipients) are:
  Tablet core: hypromellose, powdered cellulose, lactose monohydrate, anhydrous colloidal silica and magnesium stearate.
  Film coating:hypromellose, macrogol 400 and titanium dioxide (E171).

Prolonged-release tablets are white, round, slightly biconvex film-coated tablets.

The tablets are available in boxes of 10, 14, 15, 20, 30, 50, 60, 90 and 100 tablets in blister packs.

Not all pack sizes may be marketed.